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Abstract
Background ‘Choke vessels’ are thought to dilate in the first 72 h when blood flow to an area is disrupted. This study used ‘high
cut-off’ microdialysis catheters in clinical research to investigate factors mediating circulatory change within free flaps.
Methods Six patients undergoing DIEP flap breast reconstruction each had three ‘high cut-off’ microdialysis catheters, with a
membrane modification allowing molecules as large as 100 kDa to pass, inserted into Hartrampf zones 1, 2 and 4 to assess
multiple vascular territories. Microdialysis continued for 72 h post-operatively. Samples were analysed for interleukin-6 (IL-6),
tumour necrosis factor alpha (TNFα) and fibroblast growth factor basic (FGFβ).
Results Three hundred and twenty-four samples were analysed for IL-6, FGFβ and TNFα totalling 915 analyses. IL-6 showed an
increasing trend until 36 h post-operatively before remaining relatively constant. Overall, there was an increase (p < 0.001) over
the time period from 4 to 72 h, fitting a linear trend. TNFα had a peak around 20–24 h before a gradual decrease. There was a
significant linear time trend (p = 0.029) between 4 and 76 h, decreasing over the time period. FGFβ concentrations did not appear
to have any overall difference in concentration with time. The concentration however appeared to oscillate about a horizontal
trend line. There were no differences between the DIEP zones in concentrations of cytokines collected.
Conclusion This study uses high-cut off microdialysis catheters to evaluate changes in cytokines, and requires further research to
be undertaken to add to our knowledge of choke vessels and flap physiology.
Level of evidence: Level IV, diagnostic study.
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Introduction
Flap design is based on the concept of angiosomes or
perforasomes, three-dimensional blocks of tissue supplied by
a source artery and vein [1, 2]. These territories are linked to
adjacent territories by reduced calibre anastomotic vessels the-
oretically known as ‘choke vessels’ [3]. Choke vessels are
thought to dilate in the first 72 h when blood flow to an area
is disrupted, with high to low pressure flow, either following
surgical delay where the flap is raised in stages [4], or follow-
ing immediate flap transfer. This dilation continues for 7 days
at which point the choke vessels are thought to become irre-
versibly larger diameter vessel. The physiological mechanism
of choke vessel opening has yet to be elucidated. This clinical
study was designed to use microdialysis technique in investi-
gation of mediators that may be influential in the increase in
perfusion in the first 72 h after flap transfer, using the DIEP
flap as the angiosome model.
Microdialysis catheters function by using a semipermeable
membrane (usually allowing molecules of up to 20 kDa to
pass) and a dialysis fluid, collecting the dialysate to be
analysed in a microvial. Microdialysis catheters used in this
study have a modification of the semipermeable membrane
allowing molecules of up to 100 kDa to be measured as has
been validated in previous clinical research studies [5–7].
The purpose of the study was to use microdialysis to assess
larger molecules in the tissue chemistry in relation to the pe-
riod of choke vessels opening following free flap transfer,
using DIEP breast reconstruction as the model. The intraop-
erative sites of insertion for the microdialysis catheters in this
study were labelled using the original Hartrampf zones [8] 1, 2
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(contralateral midline) and 4, each zone representing an
angiosome (with appreciation that zones 2 and 3 have been
switched, Holm’s zones [9]). Zones 1 and 4 were specifically
chosen to represent contrasting quality of perfusion across the
flap.
Samples were analysed for three cytokines chosen for be-
ing implicated in changes in circulation and shown in animal
studies to upregulate in flaps; markers of inflammatory re-
sponse tumour necrosis factor alpha (TNFα, 26 kDa) and
interleukin 6 (IL-6, 22–27 kDa), and angiogenic factor fibro-
blast growth factor basic (FGFβ or FGF2, 18 kDa).
Materials and methods
Following Ethics Committee approval (in accordance with
Helsinki Declaration 1975) and informed consent of the par-
ticipants, 6 patients, mean age 44.8 years (range 36–60 years)
and a mean body mass index of 26.4, undergoing immediate
DIEP flap breast reconstruction following mastectomy for
breast cancer, participated in this study.
‘High cut-off’ microdialysis catheters (CMA) were used,
with a dialysing membrane (10 mm length) allowing mole-
cules up to 100 kDa to pass.
Intraoperatively, each patient had three high cut-off micro-
dialysis catheters, a, b and c, inserted into DIEP flap zones 1, 2
and 4 respectively. Three microdialysis pumps, set at a flow
rate of 0.3 μl/min perfused isotonic ‘perfusion fluid T1’ (Na+
147 mmol/l, K+ 4 mmol/l, Ca2+ 2.3 mmol/l and Cl−
156 mmol/l) through the catheters, and the microvials
collecting dialysate were changed every 4 h. The catheters
were secured with an occlusive dressing.
Microdialysis continued for 76 h and vials were collected
every 4 h from all three catheters and immediately stored in a
− 80 °C freezer. Analysis was performed using enzyme-linked
immunosorbent assay, ELISA (Quantikine High Sensitivity,
R&D Systems) to detect human IL-6, FGFβ and TNFα.
Results
The average ischaemia time during DIEP transfer and anasto-
mosis was 93 min (range 56–135 min), and the mean flap
weight 670 g (range 460–1030 g). The flaps were all based
on medial perforators. Our patients had no complications re-
lated to the use of microdialysis catheters, and no patient suf-
fered partial flap necrosis.
All six patients’ samples were analysed for IL-6, FGFβ and
TNFα.
Patient 4 did not have zone 4 transferred with the flap and
therefore only had two catheters, a and b in zones 1 and 2.
Patient 5 had no collection beyond 56 h due to the catheters
dislodging inadvertently following examination for a
haematoma. Patient 4 did not have a 4th zone in the flap and
therefore no catheter c, and patient was not analysed for FGFβ
due to a technical error. Three hundred and twenty-four sam-
ples were analysed by high sensitivity ELISA for each IL-6
and TNFα, and 267 for FGFβ, totalling 915 analyses from
324 vials.
The method of residual maximum likelihood (REML) was
used to fit the data to a linear model, (GenStat) with fixed
effects of time (T) and catheter (C), the two-factor interaction
T.C, and the random effect of patient (P), with interactions P.T
and P.C, with a three factor interaction P.T.C estimating the
error of variance.
Interleukin-6
Figure 1 shows the mean concentration averaged over all 6
patients, and Fig. 2 the predicted mean concentration by time.
There is an initial increase to 16 h, followed by relatively
constant concentrations until about 52 h, then a decline.
Concentrations in catheter c (zone 4) tend to be the greatest
although there is no clear separation, and this is not the same at
all time points.
Statistical significance was assessed using approximate F
tests of main effects and interactions. The effect of catheter is
not significant (p = 0.580, p = 0.592). The effects of time, in a
linear trend, are significant (p < 0.001). Effects of time in a
non-linear trend are not significant (p = 0.106). The concen-
tration of interleukin-6 (IL-6) therefore tends to increase
(p < 0.001) over the period form 4 to 72 h, and this can best
be explained by a linear trend.
Tumour necrosis factor alpha
Patients’ samples were analysed as for IL-6 and FGFβ (Figs. 3
and 4), the predicted concentrations by time. There do not
appear to be any uniform differences between catheters and
there was no obvious time trend.
The results of tests of fixed effects are shown in Table 2.
The test of interaction (C.T) shows that there is no evidence
that the linear trend in concentration differs between catheters
(p = 0.503). Considering the effect of time, tumour necrosis
factor alpha has a significant linear trend (p = 0.029, and p =
0.028 with catheter fitted first). There appears to be a peak
concentration around 16–20 h, and overall a slightly decreas-
ing time trend is apparent which is statistically significant. The
value of the estimated trend was equal to − 0.004 μg/ml per
hour.
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Fibroblast growth factor basic
The five patients’ samples in microdialysis vials were
analysed for fibroblast growth factor basic (FGFβ) (patients
1, 2, 3, 5 and 6). The vials as before were collected every 4 h
from catheters a, b and c. The mean concentrations for five
patients are in Fig. 5, and the predicted concentrations by time
in Fig. 6. There did not appear to be any uniform differences
between catheters and no obvious time trend. There did how-
ever appear to be a pattern of cyclical variation.
REML modelling of the log concentration produced a re-
sidual plot in which the residuals tended to decrease in
absolute magnitude with increasing mean concentration. The
square root transformation was found to be the most appropri-
ate in terms of homogeneity of variance and was used in this
analysis (hence predicted concentrations in Fig. 6
backtransformed). The differences between catheters are not
statistically significant (p = 0.719, and p = 0.698 allowing for
the effect of time). Considering the effect of time, the linear
trend is not statistically significant (p = 0.530 and p = 0.535
allowing for the effect of the catheter). However, the non-
linear effects of time are on the borderline of statistical signif-
icance (p = 0.050 not allowing for catheter, p = 0.049 allowing
for catheter). There does appear to be a cyclical variation in
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Fig. 1 Mean concentration
averaged over 6 patients versus
time, by catheter, IL-6
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FGFβ concentration which may explain these border line F-
statistics for the non-linear effects of time, which may be
oscillations about the trend line of biological significance.
Discussion
Understanding the vascular territories of the skin, angiosomes
[3, 10] and perforasomes [2], and the concept of safely cap-
turing several vascular territories in flap design with detailed
knowledge of the vascular anatomy, has improved the design
and safety of flap transfer. The interconnections between
vascular territories, which can include ‘direct’ or ‘true anasto-
moses’ being vessels that do not change in calibre, and re-
duced calibre ‘indirect’ vessels or ‘choke vessels’ [2], relates
to the number of angiosomes that can be reliably used, and the
concept of the ‘functional angiosome’ [1]. However, the
mechanisms of choke vessel or indirect vessel opening has
yet to be elucidated, and this knowledge may lead to the abil-
ity to influence vessel opening, and increase the functional
angiosome size. This may be of great value in certain scenar-
ios of flap transfer or impending partial necrosis, and in other
forms of necrosis caused by insufficient blood supply for ex-
ample meningococcal septicaemia [1].
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Delay has been used as a mechanism for improving
flap survival and experimentally to improve understand-
ing of the chemical signalling that may be involved in the
dilation of choke vessels and intraflap vessels. Many an-
imal studies have been designed looking at the chronolog-
ical sequence that may occur in choke vessel opening [4,
11–13]. They concluded similarly that surgical delay re-
sults in dilatation of the existing vessels with maximal
effect in the zone of the choke vessels, rather than im-
proved blood flow being due to neovascularisation or an-
giogenesis. The timing of improved blood flow across
angiosomes was maximal at 48–72 h [4, 13], with a
marked increase in diameter in vessels in the flap partic-
ularly in the zone of the choke vessels [4, 11, 13]. A
detailed study by Dhar and Taylor in 1999 [13] involved
200 rabbits and 17 dog models to look at choke arterioles
in the early and late post delay period. They summarised
that events due to delay occurred in four phases, phase 1
representing the initial vasoconstriction and then vasodi-
lation up to 24 h, with phase two occurring between 24
and 72 h, especially between 48 and 72 h with an accel-
erated increase in vessel diameter especially at the choke
vessel level with cell division in the vessel wall. Phase 3
occurred between 72 h and 7 days with more gradual
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dilation, and phase 4 from 7 days to 1 year with perma-
nent dilation of the choke vessels. In planning our clinical
study, we therefore decided to focus on the first 4 days
following DIEP flap transfer to investigate cytokines that
may relate to this process.
Mechanisms of active dilation of the choke vessels
proposed include physical changes such as the pressure,
‘stretch’ and pulsatile effect of the blood flow [13], reac-
tive hyperaemia (and hyperadragenergic) states in the
proximal zones [14], and chemical mechanisms where is-
chaemia may act as the primary stimulus, and although
known to stimulate neovascularisation [13] (via hypoxia
inducible factors HIF [15, 16]) hypoxia has a less clear
effect on choke vessels. Pharmacological agents that have
experimentally increased flap survival in animals include
guanethidine [17], topical nitroglycerine [17, 18], prosta-
glandin E1 and E2 [17, 19, 20], FGFβ [21], platelet-
derived growth factor (PDGF) [22] and thromboxane A2
synthase inhibition [23]. Decreases in survival have been
shown with thromboxane, prostaglandin F1α [23] and
epinephrine [24]. And finally, there is still the question
of why choke vessel dilation becomes permanent.
In this novel clinical study using microdialysis catheters, we
chose three cytokines previously shown in animal studies to
upregulate in flaps [25–29]. IL-6 and tumour necrosis factor
alpha (TNFα) are both involved in signalling the acute phase
response and fever, and are inflammatory cytokines, and play
key roles in the cross-talk between cytokines. IL-6 is an impor-
tant pro-inflammatory mediator that can promote the release of
TNFα by activating leukocytes, and TNFα is one of the most
important pro-inflammatory cytokines. FGFβ is part of a family
of growth factors involved in wound healing, embryonic devel-
opment and is one of the most powerful angiogenic factors
identified.
Many animal studies of flaps have been performed to
look at dermal cytokine expression with an aim of under-
standing flap ischaemia. In 1995, Most et al. [26] per-
formed a rat study using dorsal flaps with biopsies taken
at 0, 8, 16, 24 and 48 h after the flaps were raised and at
varying distances from the end of the flap (0.5 cm to
10 cm). Cytokine expression was examined with the
highest detected at 8 h post-operatively for PDGF,
transforming growth factor beta (TGFβ) and FGFβ, and
each of these cytokines had a 20-fold increase (p < 0.002).
IL-6 expression was also highest at 8 h with a 14-fold
increase. Authors noted that there was a dramatic and
early cytokine expression at flap bases compared with
their ischaemic tips. Our study similarly did not find in-
creased cytokines in zone 4 furthest from the pedicle,
although there was no significant difference in cytokine
concentration in any of the zones.
In a delayed TRAM flap model in rats published by
Wong et al. in 2004 [27], FGFβ was measured by biopsy
and enzyme-linked immunosorbent assays. A surgical de-
lay was performed 7 days (n = 12), 14 days (n = 10) or
21 days (n = 7) before the flap was raised. FGFβ was
found to be significantly higher in all delayed flaps than
the control flaps with no delay (n = 6) at day 3 post-oper-
atively. There was no difference in FGFβ across zones 1–
4. The authors concluded that the increase in FGFβ at day
3 in delayed flaps may be a factor in improved flap via-
bility, and that further investigation was required.
Lineaweaver et al. demonstrated a significant increase in
cytokine expression of FGFβ and vascular endothelial
growth factor (VEGF) in delayed rat TRAM flaps post-
operatively, again with no significant differences between
zones [28].
Cytokine expression is also increased following ischae-
mia-reperfusion. A rat study by Zhang et al. in 2005 sub-
jected rat gracilis muscle to two episodes of ischaemia, a
primary episode for 1 h and then a 24 h later a secondary
ischemia of 4 h [29]. Gene expression of TNFα,
interleukin-1 beta (IL-1β) and PDGF mRNA was deter-
mined by PCR at 4 and 18 h after the primary ischaemia
and at 0, 4 and 18 h after the secondary ischaemia. IL-1
was upregulated 4 h after the primary ischaemia and
PDGF was upregulated immediately after the secondary
ischaemia. TNFα was significantly upregulated 18 h after
secondary ischaemia. Our highest concentration of TNFα
was at 16 h, and this was significantly higher than the
concentration at 12 h post-operatively (p = 0.002).
A more recent animal studies by Mao in 2019 used
biopsies in choke vessel zones of mice flaps to compare
single and multiple perforator based flaps [30]. Blood
flow in the choke zones was measured by laser Doppler
flowmetry at 6 h, 1, 3, 5 and 7 days. Histological analysis
showed morphological changes including increase tortu-
osity, dilation and thickened walls of choke vessels, with
expansion into the choke zone by day 3. Endothelial nitric
oxide synthase (eNOS), metalloproteinase 2 (MMP-2),
hypoxia-inducible factor 1α (HIF-1α) and intercellular
adhesion molecule 2(ICAM-2) were measured at these
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time points. Endothelial NOS increased expression at 6 h,
endothelium being the first site stimulated by shear stress.
MMP-2, secreted by macrophages, is associated with vas-
cular remodelling and had significantly increased by days
1 and 3 and HIF-1α and ICAM-2 increased by day 3. Luo
et al. in 2019 similarly investigated the haemodynamic
and morphological changes in choke vessels in a new rat
flap model, investigating the role of known angiogenic
factors HIF-1α, iNOS and VEGF in the choke zone
[16]. Histologically, choke vessels were open at day 3
and microvascular density increased until day 5, with
iNOS significantly increased on day 1 (consistent with
massive opening of choke vessels) before gradually de-
creasing, and HIF-1α expression reached a maximum at
day 5 post-operatively. Luo et al. demonstrated previous
experimental knowledge that HIF-1α expression may be
involved in the early vascular remodelling process by in-
ducing iNOS and VEGF expression. Morphological ele-
ments of both these animal studies demonstrate choke
vessels opening in first few days as originally proposed
by Taylor et al. [3, 13], and also provide further insight as
known angiogenic factors are present in the choke vessel
zones at a time when the choke vessels are becoming true
anastomosis. Luo et al. also make the point that there are
no previous animal studies with single pedicle multi-
territory perforator models until theirs, a model that would
be comparable with clinical DIEP flaps again highlighting
the need for more animal but also clinical studies for
further understanding of the processes of choke vessel
dilation permanence and partial necrosis [16].
Manipulation of flap survival has been attempted in
many animal studies, largely based on the knowledge of
theoretical negative impact of pro-inflammatory cyto-
kines, such as TNF alpha and IL-6 that we have investi-
gated, and pro-angiogenic factors such as FGFβ and
VEGF [25, 31, 32]. TGFβ, fibroblast growth factor, en-
dothelial growth factor and VEGF have shown some of
the more impressive results in flap survival [21, 32–43].
Many of the outcome markers examine the percentage of
flap necrosis at 1 week post-operatively, reflecting a num-
ber of processes including the opening of choke vessels in
the initial few days and angiogenesis contributing there-
after, and any effects ischaemia-reperfusion injury during
free flap transfer. In addition, application of growth fac-
tors to flaps range from the time of raising the flap to as
much as 10 days pre-operatively, further complicating
extrapolation of timing in relation to choke vessels.
Similarly, targeting the negative effects of inflammatory
factors, Enteracept, a soluble TNFα binding protein, has
been shown to offer protection against ischaemia reperfu-
sion injury in a rat transverse rectus abdominus
myocutaneous (TRAM) flap model [44]. Use of growth
factors have also reduced the expression of inflammatory
mediators [45]. Other studies demonstrate success with
hirudin [25, 46] by improving microcirculation, but also
by reducing inflammation. These studies present further
possibilities for increasing flap survival.
Clinically, varying scenarios would need to be encoun-
tered to appreciate patterns of cytokine release in relation
to outcome, including partial necrosis. There may be dif-
ferences across zones and with time, and also between
different flap compositions [47]. The use of microdialysis
catheters is a more acceptable method of investigation of
cytokine levels than biopsies as used in animal studies.
Microdialysis fluid can be collected continuously and
high cut-off catheters would appear to collect cytokines
IL-6, FGFβ and TNFα all less than 100 kDa. It would be
useful to directly compare the levels of cytokines in biop-
sy specimens with microdialysis catheters. Whilst it may
seem desirable to have a non-flap catheter to measure
systemic response to surgery and catheter insertion, the
investigation of choke vessels is an intra-flap phenome-
non (with zone 1 as the baseline). The use of high cut-off
catheters as a research tool in plastic surgery is not report-
ed in the literature, and without further study it is difficult
to ascertain whether there could be confounding factors in
the measurement of molecules observed in the biological
setting. For example, could circulating molecules close to
the membrane pore size cause temporary occlusions alter-
ing the amount of researched molecule reaching the
microvial? We chose a low flow rate through the micro-
dialysis pumps to maximise the concentration of cytokine
collected, necessitating a minimum of 4 hourly intervals
which is still more frequent than 12 h biopsy intervals in
many animal studies.
Conclusions
Microdialysis using high-cut off membrane catheters,
allowing the sampling of larger molecules such as cyto-
kines, has been used to investigate the cytokine changes
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that occur across multiple angiosomes following flap sur-
gery. Further research and a better understanding of this
initial time period when choke vessel opening occurs may
ultimately allow manipulations to avoid partial necrosis
and improve the vascular territory.
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